Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.
about
The spread, treatment, and prevention of HIV-1: evolution of a global pandemicThe failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategiesNonpathogenic simian immunodeficiency virus infectionsSynthetic DNA vaccine strategies against persistent viral infectionsNatural SIV hosts: showing AIDS the doorThe simian immunodeficiency virus targets central cell cycle functions through transcriptional repression in vivoVaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protectionFunctional impairment of central memory CD4 T cells is a potential early prognostic marker for changing viral load in SHIV-infected rhesus macaquesDifferent Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope SpecificityTRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus MonkeysCo-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cellsA phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responsesIn vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteersPriming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responsesImmune-correlates analysis of an HIV-1 vaccine efficacy trialEpitope specific T-cell responses against influenza A in a healthy population.Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine.Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide.Human immunodeficiency virus vaccine trialsDNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.Post-infection immunodeficiency virus control by neutralizing antibodiesInduction of human immunodeficiency virus (HIV-1) envelope specific cell-mediated immunity by a non-homologous synthetic peptideSelf-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239.Envelope vaccination shapes viral envelope evolution following simian immunodeficiency virus infection in rhesus monkeys.Mucosal IgA and IFN-γ+ CD8 T cell immunity are important in the efficacy of live Salmonella enteria serovar Choleraesuis vaccinesDivergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections.Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic toleranceA phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).Contributions of Mamu-A*01 status and TRIM5 allele expression, but not CCL3L copy number variation, to the control of SIVmac251 replication in Indian-origin rhesus monkeysHIV-1 vaccine development after STEP.Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response.Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay.Simian-human immunodeficiency infection--is the course set in the acute phase?Early divergent host responses in SHIVsf162P3 and SIVmac251 infected macaques correlate with control of viremia.HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cellsA model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice.
P2860
Q22241890-C9A2D5D7-A268-4A02-92E8-33A1A4EC00D4Q24652185-76B76A1A-1CC1-474D-8DCC-663C82725F8FQ26799624-22C3C09F-70EA-4855-AD42-BEE344ABE343Q27004065-00AD2CD1-64B1-4AB6-BAD7-54C433451B8CQ27016078-E4FDFB9D-D614-4567-B974-58A50D834A0AQ27026135-F7B6DB97-25DC-483A-B929-A83FFA92C0C1Q27317391-DBFB7C0D-AB8A-4950-989C-59385CFA2DD9Q27332360-49B26834-30C1-4142-90BA-592A6DF838B2Q27342763-BB1F31A3-379F-4E3C-B53A-B4CA0B6AEFB0Q27646554-F22FFD2B-3D2C-4B89-9031-BAD447660F28Q28472608-9BF95ADC-593F-4CCE-A058-AE4326DF2B04Q28732043-6BC3FA7C-CEF5-4B69-A16E-834B9F3307B3Q28741673-C92836D9-81BE-4F45-953E-9D314420418FQ28742853-5498BDA2-D49D-4E1C-B181-4C13B2253EB2Q28744555-7B1C2EF4-BDBA-4940-BDCF-A3591CBC77E5Q28749120-9647C409-5671-49EF-9C56-7A36E1A85E53Q29617377-BB71CF9B-850F-46E4-A512-866E28A31EB1Q30202358-1E1C3552-D630-4010-85B4-87538AF91A38Q30378897-E6E1B7DD-CC57-4C01-8200-69AC699680A2Q30404738-4C680294-BB1A-4166-82C3-712D682AD163Q30424366-D41F57F0-EAC4-4274-A5C6-24AD20362AAEQ33268303-A01E4B00-A871-402F-9FA6-5168A912B4B8Q33288264-E5A2AE40-6B55-4940-898C-A7277442DDF5Q33307523-1C1587D2-B95B-4925-ABD0-0EEC892086D1Q33378492-1ABFDF28-D5AC-4A8D-961D-593266039650Q33402455-6F008A53-F74B-45B6-B8D3-D1EB618C0606Q33558407-92A47B81-0683-4435-A699-A2E8D32F324FQ33560074-82B32356-75AA-4DB3-8756-8509BF301776Q33573749-B4EC9D51-B6F1-4E05-92FE-A8A2C26B0AA8Q33591736-A2AA1ABB-0ED7-4355-B520-C9B803EFF2ACQ33611719-C9C96F9E-6493-4C5C-953D-03A85774DD4DQ33619206-9D11EA65-F1B5-43DA-A138-71D4FCF4501DQ33642318-37C43562-AE91-4BB8-B17C-4CDE85F1B096Q33737476-62298FC4-E898-4426-BEFC-A174F1E54CE2Q33763297-89846F72-D041-447D-99DA-36104E944F41Q33807535-E13B8919-1083-4D21-8FDC-C68F68BDF843Q33831899-03C9524A-654E-4845-AC10-3FD0C6C51D1FQ33862618-B3FF72B6-86E9-4A59-8B6F-C065AC6387C4Q33990552-45FEC120-3BA3-4A75-8364-37FC4D1CCE16Q34034274-3740A572-4D2F-4446-9B78-428AD2996A5C
P2860
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.
@ast
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.
@en
type
label
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.
@ast
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.
@en
prefLabel
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.
@ast
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.
@en
P2093
P2860
P50
P356
P1433
P1476
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.
@en
P2093
Adam P Buzby
Bimal Chakrabarti
Darci A Gorgone
Fred L Bookstein
Jörn E Schmitz
Norman L Letvin
Srinivas S Rao
P2860
P304
P356
10.1126/SCIENCE.1124226
P407
P577
2006-06-01T00:00:00Z